Development of New Carbohydrate Synthesis Methodologies
新碳水化合物合成方法的开发
基本信息
- 批准号:7623865
- 负责人:
- 金额:$ 23.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-03-01 至 2010-05-31
- 项目状态:已结题
- 来源:
- 关键词:AnticoagulantsAnticoagulationBacterial InfectionsBiologicalBiological ProcessCarbohydratesChemicalsComplexCouplingDevelopmentDue ProcessElectronsEventGlycoconjugatesHeparinInflammationInorganic SulfatesKnowledgeLabelLearningLeftLengthMeasuresMediator of activation proteinMethodologyMethodsMonitorNatureNeoplasm MetastasisOligonucleotidesOligopeptidesOligosaccharidesPatternPhasePhysiological ProcessesPlayPreparationProcessPropertyProtocols documentationReactionResearchResearch PersonnelRoleRouteSamplingSeriesSolidSolutionsSolventsStructureStructure-Activity RelationshipSulfurTemperatureThioglycosidesTimeUnspecified or Sulfate Ion Sulfatesbasecancer cellchemical synthesischitosan sulfatecold temperaturedesignflasksglycosylationinsightmolecular sievingnovelnovel strategiesprogramspromoterresearch studysuccesssulfation
项目摘要
DESCRIPTION (provided by applicant): A research program devoted to the development of new methods for carbohydrate synthesis and studies of their biological activities is proposed. Carbohydrates and glycoconjugates are mediators of many medicinally important physiological processes, such as cancer metastasis, inflammation, anticoagulation and bacterial infection. Chemical syntheses of oligosaccharides are crucial for providing pure samples for glycobiological studies. Traditional carbohydrate synthesis is a time-consuming process due to tedious protective group manipulation and intermediate purification. Two novel one-pot approaches where multiple glycosylation reactions can be carried out in a single reaction flask without separation of synthetic intermediates are proposed. The first proposed method utilizes glycosyl building blocks with anomeric activities tuned through aglycons with various electron withdrawing power and building blocks with multiple levels of reactivity can be derived from a common intermediate. This will greatly expand the reactivity window and reduce the time and efforts for building block preparation. The second proposed strategy is based on pre-activation of glycosyl donors in the absence of acceptors, which can be carried out iteratively independent of donor anomeric reactivities. The iterative one-pot method represents a general and powerful approach, which can potentially become a fully automated solution-phase based carbohydrate synthesis method. Mechanisms of the two proposed methods will be investigated and the lessons learned will be applied for further development. To demonstrate the broad applicability of proposed strategies, a complex type bi-antennary dodecasaccharide and a series of sulfated chitosanoligosaccharides will be synthesized. The anticoagulant properties of the sulfated chitosanoligosaccharides will be determined for better understanding of their structure-activity relationship and development of more potent anticoagulants.
描述(由申请人提供):提出了一项致力于开发碳水化合物合成新方法及其生物活性研究的研究计划。碳水化合物和糖缀合物是许多医学上重要的生理过程的介质,如癌症转移、炎症、抗凝和细菌感染。寡糖的化学合成对于为糖生物学研究提供纯净样品至关重要。传统的碳水化合物合成是一个耗时的过程,由于繁琐的保护基操作和中间体纯化。提出了两种新的一锅法,其中多个糖基化反应可以在一个单一的反应烧瓶中进行,而不分离的合成中间体。第一种提出的方法利用具有异头活性的糖基结构单元,该异头活性通过具有各种吸电子能力的糖苷配基进行调节,并且具有多个反应性水平的结构单元可以从共同的中间体衍生。这将极大地扩大反应窗口,并减少构建块制备的时间和精力。第二个提出的策略是基于在不存在受体的情况下糖基供体的预活化,其可以独立于供体异头反应性迭代地进行。迭代一锅法代表了一种通用的和强大的方法,它可能成为一个完全自动化的基于溶液相的碳水化合物合成方法。将对这两种拟议方法的机制进行调查,并将吸取的经验教训用于进一步发展。为了证明所提出的策略的广泛适用性,将合成复合型双触角十二糖和一系列硫酸化壳寡糖。硫酸化壳寡糖的抗凝血性能将被确定,以更好地了解其结构-活性关系和开发更有效的抗凝血剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xuefei Huang其他文献
Xuefei Huang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xuefei Huang', 18)}}的其他基金
Synthetic glycan conjugates with bacteriophage Qbeta for broad spectrum anti-salmonella vaccines
用于广谱抗沙门氏菌疫苗的合成聚糖与噬菌体 Qbeta 缀合物
- 批准号:
10432065 - 财政年份:2019
- 资助金额:
$ 23.96万 - 项目类别:
Synthetic glycan conjugates with bacteriophage Qbeta for broad spectrum anti-salmonella vaccines
用于广谱抗沙门氏菌疫苗的合成聚糖与噬菌体 Qbeta 缀合物
- 批准号:
9978709 - 财政年份:2019
- 资助金额:
$ 23.96万 - 项目类别:
Synthetic glycan conjugates with bacteriophage Qbeta for broad spectrum anti-salmonella vaccines
用于广谱抗沙门氏菌疫苗的合成聚糖与噬菌体 Qbeta 缀合物
- 批准号:
10201474 - 财政年份:2019
- 资助金额:
$ 23.96万 - 项目类别:
Synthetic glycan conjugates with bacteriophage Qbeta for broad spectrum anti-salmonella vaccines
用于广谱抗沙门氏菌疫苗的合成聚糖与噬菌体 Qbeta 缀合物
- 批准号:
10653943 - 财政年份:2019
- 资助金额:
$ 23.96万 - 项目类别:
Engineering bacteriophage Qβ conjugates with tumor associated carbohydrate antigens as multi-component anti-cancer vaccines
工程噬菌体 Qβ 与肿瘤相关碳水化合物抗原缀合物作为多组分抗癌疫苗
- 批准号:
9473167 - 财政年份:2018
- 资助金额:
$ 23.96万 - 项目类别:
Stereoselective Assembly of Challenging Glycosidic Linkages with Earth-Abundant Metal Catalysts
用地球上丰富的金属催化剂立体选择性组装具有挑战性的糖苷键
- 批准号:
9546030 - 财政年份:2018
- 资助金额:
$ 23.96万 - 项目类别:
Engineering bacteriophage Qβ conjugates with tumor associated carbohydrate antigens as multi-component anti-cancer vaccines
工程噬菌体 Qβ 与肿瘤相关碳水化合物抗原缀合物作为多组分抗癌疫苗
- 批准号:
10358502 - 财政年份:2018
- 资助金额:
$ 23.96万 - 项目类别:
Stereoselective Assembly of Challenging Glycosidic Linkages with Earth-Abundant Metal Catalysts
用地球上丰富的金属催化剂立体选择性组装具有挑战性的糖苷键
- 批准号:
10173059 - 财政年份:2018
- 资助金额:
$ 23.96万 - 项目类别:
Engineering bacteriophage Qβ conjugates with tumor associated carbohydrate antigens as multi-component anti-cancer vaccines
工程噬菌体 Qβ 与肿瘤相关碳水化合物抗原缀合物作为多组分抗癌疫苗
- 批准号:
10540343 - 财政年份:2018
- 资助金额:
$ 23.96万 - 项目类别:
Virus like particles as carriers for carbohydrate based anti-Salmonella vaccines
病毒样颗粒作为碳水化合物抗沙门氏菌疫苗的载体
- 批准号:
9118056 - 财政年份:2015
- 资助金额:
$ 23.96万 - 项目类别:
相似海外基金
An Anticoagulation-Free Artificial Placenta Device
一种免抗凝人工胎盘装置
- 批准号:
10741704 - 财政年份:2023
- 资助金额:
$ 23.96万 - 项目类别:
Research Supplement to Promote Diversity Supplement for the ECMO without Anticoagulation
研究补充促进无抗凝 ECMO 的多样性补充
- 批准号:
10712181 - 财政年份:2023
- 资助金额:
$ 23.96万 - 项目类别:
心原性ショックに対するTheragnostic Anticoagulationに向けた生体応答ダイナミクス
治疗诊断抗凝治疗心源性休克的生物反应动力学
- 批准号:
23K19561 - 财政年份:2023
- 资助金额:
$ 23.96万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Net Clinical Benefit and Cost-Effectiveness of Indefinite Anticoagulation Among Clinically Relevant Subgroups of Patients with First Unprovoked Venous Thromboembolism
首次无端静脉血栓栓塞临床相关亚组患者无限期抗凝的净临床效益和成本效益
- 批准号:
493128 - 财政年份:2023
- 资助金额:
$ 23.96万 - 项目类别:
Combined Use of Polycarboxybetaine Coatings with a Selective FXIIa Inhibitor to Create Potent Biomaterial Anticoagulation Without Bleeding During Extracorporeal Life Support
聚羧基甜菜碱涂层与选择性 FXIIa 抑制剂的组合使用可在体外生命支持期间产生有效的生物材料抗凝作用而不会出血
- 批准号:
10444025 - 财政年份:2022
- 资助金额:
$ 23.96万 - 项目类别:
2/2 REACT-AF: Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation
2/2 REACT-AF:通过连续监测心房颤动进行抗凝心律评估
- 批准号:
10509053 - 财政年份:2022
- 资助金额:
$ 23.96万 - 项目类别:
Effectiveness and Safety of Transcatheter Left Atrial Appendage Occlusion vs. Anticoagulation in Older Adults with Atrial Fibrillation and Alzheimer's Disease and Related dementias
经导管左心耳封堵术与抗凝治疗对患有心房颤动、阿尔茨海默病及相关痴呆症的老年人的有效性和安全性
- 批准号:
10672458 - 财政年份:2022
- 资助金额:
$ 23.96万 - 项目类别:
The Rhythm Evaluation for Anticoagulation with Continuous Monitoring of Atrial Fibrillation Trial (REACT-AF)
心房颤动连续监测试验的抗凝节律评估 (REACT-AF)
- 批准号:
10509310 - 财政年份:2022
- 资助金额:
$ 23.96万 - 项目类别:
A Low Blood Volume Platform for Recurrent Anticoagulation and Kidney Monitoring during Continuous Renal Replacement Therapy in Critically Ill Children
危重儿童连续肾脏替代治疗期间反复抗凝和肾脏监测的低血容量平台
- 批准号:
10383224 - 财政年份:2022
- 资助金额:
$ 23.96万 - 项目类别:
A Low Blood Volume Platform for Recurrent Anticoagulation and Kidney Monitoring during Continuous Renal Replacement Therapy in Critically Ill Children
危重儿童连续肾脏替代治疗期间反复抗凝和肾脏监测的低血容量平台
- 批准号:
10820748 - 财政年份:2022
- 资助金额:
$ 23.96万 - 项目类别: